COURSE OVERVIEW
Evidence In ACTION: Asymmetrical High Flow Therapy Part 3: Insights and Outcomes
1 CE AARC
Online Video
Skip to course content
Enrollment Status
Not Enrolled
Enrollment
Program Summary
Asymmetrical High Flow Therapy Part 3: Insights and Outcomes
Presenter: Chris Hutchinson, PGDip BE
Date: June 25, 2026
Course Description
Asymmetrical High Flow Therapy Part 3: Insights and Outcomes provides an advanced, practice-focused review of asymmetrical high flow therapy across a range of clinical care settings. Presented by Chris Hutchinson, PGDip BE, this activity examines implementation strategies, evaluates patient outcomes and clinical responses, and highlights practical insights that can support more effective use of asymmetrical high flow therapy.
Participants will explore how current evidence and real-world experience can be translated into clinical decision-making, with an emphasis on optimizing therapy delivery, assessing treatment response, and improving patient outcomes across diverse healthcare environments.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Evaluate asymmetrical high flow therapy implementation strategies across care settings.
- Analyze asymmetrical high flow therapy outcomes and patient responses.
- Apply clinical insights to optimize asymmetrical high flow therapy practice.
Objectives
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the physiological principles underlying high-flow therapy.
- Review the latest clinical evidence supporting the use of high-flow therapy for critically ill patients in the intensive care unit (ICU).
- Implement evidence-based strategies for utilizing high-flow therapy in the ICU to optimize patient outcomes.